phase1-2 · 2025
iPSC-derived dopaminergic neuron transplantation in Parkinson's disease
Reports procedural safety and graft survival in small numbers of participants; motor outcomes require long-term follow-up.
ClinicalTrials.govTreatment example
Care journey example: Parkinson's disease
What people with Parkinson's disease and their families actually encounter when asking about stem cell studies.
In short
Levodopa and multidisciplinary care remain the mainstay. Stem cell studies in Parkinson's are early-stage with very few participants; any consideration must go through a neurologist with long-term follow-up.
Step by step
Timings are a general example and may change with documents and clinical judgement.
- 01
Send your question and basic information
Day 1Complete the information-consultation form with your symptoms, how long you have had them, current medicines and previous treatments. The EHL Thailand information team replies in your dashboard. This step is educational information, not a diagnosis.
Who is involved: You + EHL Thailand information team
- 02
Collect your medical documents
Week 1–2Prepare discharge/treatment summaries, blood results, X-ray or MRI images and your medicine list. The more complete the records, the more accurate the eligibility review. Documents are used only with your consent (PDPA).
Who is involved: You + your current treating doctor
- 03
Review the research evidence together
Week 2The team explains that iPSC studies in Parkinson's are early trials focused on safety and graft survival, and that public detail on EHL BIO's PDSTEM Inj. is limited.
Who is involved: Information team + content review panel
- 04
Clinical eligibility screening
Week 3–4A neurologist confirms the diagnosis and assesses disease stage, levodopa response, co-existing dementia and caregiver readiness.
Who is involved: The doctor or clinic responsible for care in Korea
- 05
Informed consent before deciding
Before travellingBefore deciding you should receive documents stating that the treatment is investigational and not registered in Thailand, the risks, the alternatives, the full costs, and what is still unknown. No outcome guarantee should ever be given.
Who is involved: You + the treating doctor
- 06
Treatment and follow-up
From treatment day to 12 monthsMotor scores, falls, sleep and quality of life are followed every 3 months for at least 12 months.
Who is involved: Treating doctor + your doctor in Thailand
Documents to prepare
- Diagnosis summary from a neurologist
- Medicine list with daily dosing times
- Video of on/off symptoms if available
- Recent brain imaging (MRI/CT)
Questions to ask your doctor
- Is this true Parkinson's disease or a parkinsonian syndrome?
- Are medicine adjustment or deep brain stimulation still options?
- What are the risks of the cell delivery procedure?
- If symptoms worsen afterwards, who is responsible for continuing care?
Limits you must know
- Stem cell treatment for these conditions remains investigational; it is not standard care.
- EHL Thailand is an information and consultation channel, not a clinic, and does not diagnose or prescribe.
- EHL BIO pipeline cell products have no published Thai registration status.
- The timings shown are a general example and may change with documents, extra tests and clinical judgement.
Related disease page
Parkinson's Disease
A neurodegenerative movement disorder caused by loss of dopamine-producing neurons.
Research cited in this journey
preclinical · 2024
PDSTEM Inj.: preclinical study in Parkinson's disease (hospital information)
The hospital's affiliated research centre states the programme is at non-clinical stage, so there are no efficacy or safety data in people with Parkinson's disease, and it is not approved treatment.
EHL BIO (research page)Experts involved
Profiles show only details checkable against public sources.
EHL BIO Stem Cell Research Institute
Stem cell therapeutics research and development team
ADSTEM (atopic dermatitis), KDSTEM (chronic kidney disease), RASTEM (rheumatoid arthritis), PDSTEM (Parkinson's disease) and adipose-derived exosome programmes
EHL BIO — Stem cell treatmentEHL Thailand Medical Information Team
Writes and reviews disease pages and stem cell topics
Evidence levels, regulatory status, and separating hospital information from medical information
Experts behind this content
EHL Thailand Medical Information Team — Evidence levels, regulatory status, and separating hospital information from medical information
EHL BIO scientific information is compiled alongside public information from its research team and GMP centre. See the full expert panel
Frequently asked questions
Last updated 3 Sept 2026